287 related articles for article (PubMed ID: 11016148)
1. Downstaging of cervical cancer.
Ananth R
J Indian Med Assoc; 2000 Feb; 98(2):41-4. PubMed ID: 11016148
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer control in developing countries: memorandum from a WHO meeting.
Bull World Health Organ; 1996; 74(4):345-51. PubMed ID: 8823955
[TBL] [Abstract][Full Text] [Related]
3. Organization of screening programs in developing countries with reference to screening for cancer of the uterine cervix in India.
Luthra UK; Rengachari R
IARC Sci Publ; 1986; (76):273-88. PubMed ID: 3570411
[TBL] [Abstract][Full Text] [Related]
4. Early detection of cervical cancer through acetic acid application--an aided visual inspection.
Singh V; Sehgal A; Parashari A; Sodhani P; Satyanarayana L
Singapore Med J; 2001 Aug; 42(8):351-4. PubMed ID: 11764051
[TBL] [Abstract][Full Text] [Related]
5. Review of screening and preventive strategies for cervical cancer in India.
Patro BK; Nongkynrih B
Indian J Public Health; 2007; 51(4):216-21. PubMed ID: 18232160
[TBL] [Abstract][Full Text] [Related]
6. [Cervical cancer in developing countries. A threat to reproductive health].
Tristen C; Bergström S
Lakartidningen; 1996 Sep; 93(39):3374-6. PubMed ID: 8926808
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of cancer of the cervix: global and national perspective.
Shanta V; Krishnamurthi S; Gajalakshmi CK; Swaminathan R; Ravichandran K
J Indian Med Assoc; 2000 Feb; 98(2):49-52. PubMed ID: 11016150
[TBL] [Abstract][Full Text] [Related]
8. Objective screening for cervical cancer in developing nations: lessons from Nigeria.
Roblyer D; Richards-Kortum R; Park SY; Adewole I; Follen M
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S94-7. PubMed ID: 17825396
[TBL] [Abstract][Full Text] [Related]
9. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening.
Misra JS; Gupta HP; Das V
Diagn Cytopathol; 2004 Dec; 31(6):376-9. PubMed ID: 15540174
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
[TBL] [Abstract][Full Text] [Related]
11. Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group.
Sankaranarayanan R; Mathew B; Jacob BJ; Thomas G; Somanathan T; Pisani P; Pandey M; Ramadas K; Najeeb K; Abraham E
Cancer; 2000 Feb; 88(3):664-73. PubMed ID: 10649262
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of visual inspection of the cervix using acetic acid in cervical cancer screening: a comparison with cervical cytology.
Akinola OI; Fabamwo AO; Oshodi YA; Banjo AA; Odusanya O; Gbadegesin A; Tayo A
J Obstet Gynaecol; 2007 Oct; 27(7):703-5. PubMed ID: 17999297
[TBL] [Abstract][Full Text] [Related]
13. Low cost methods for secondary prevention of cervical cancer in developing countries.
Anorlu RI; Ola ER; Abudu OO
Niger Postgrad Med J; 2007 Sep; 14(3):242-6. PubMed ID: 17767211
[TBL] [Abstract][Full Text] [Related]
14. Low-cost technology for screening uterine cervical cancer.
Parashari A; Singh V; Sehgal A; Satyanarayana L; Sodhani P; Gupta MM
Bull World Health Organ; 2000; 78(8):964-7. PubMed ID: 10994279
[TBL] [Abstract][Full Text] [Related]
15. Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.
Hall KL; Dewar MA; Perchalski J
Prim Care; 1992 Sep; 19(3):607-20. PubMed ID: 1410066
[TBL] [Abstract][Full Text] [Related]
16. A study of cervical cancer screening for prevention of carcinoma cervix.
Christe DM; Mohanambal M; Ramamurthy V; Snehaa NB
J Indian Med Assoc; 2008 Dec; 106(12):779-80, 782. PubMed ID: 19370947
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer prevention for all the world's women: genuine promise resides in skilled quality management rather than novel screening approaches.
Suba EJ; Donnelly AD; Furia LM; Huynh ML; Raab SS;
Diagn Cytopathol; 2007 Mar; 35(3):187-91. PubMed ID: 17304532
[TBL] [Abstract][Full Text] [Related]
18. Visual inspection for cervical cancer screening: evaluation by doctor versus paramedical worker.
Bhatla N; Mukhopadhyay A; Joshi S; Kumar A; Kriplani A; Pandey RM; Verma K
Indian J Cancer; 2004; 41(1):32-6. PubMed ID: 15105577
[TBL] [Abstract][Full Text] [Related]
19. Selective cervical cytology screening: discriminant analysis approach.
Juneja A; Murthy NS; Sharma S; Shukla DK; Roy M; Das DK
Neoplasma; 1993; 40(6):401-4. PubMed ID: 8289972
[TBL] [Abstract][Full Text] [Related]
20. Screening for cancer of uterine cervix and approaches adopted in India.
Murthy NS; Mathew A
Indian J Cancer; 1999; 36(2-4):154-62. PubMed ID: 10921220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
